Today the editors of the Wall Street Journal warn about the potential impact on the U. S. economy of the coronavirus outbreak in China:
Some of President Trump’s advisers may want to wall off the U.S. and China into separate spheres of influence, but the novel coronavirus is showing the futility of economic quarantines. Like it or not, the Chinese and world economies sniffle and cough together.
Commodities prices sank on Monday amid news that the coronavirus and resulting economic contagion are spreading. U.S. crude oil prices have fallen 20% over the last three weeks as Chinese oil demand is expected to fall by two million barrels a day and global economic growth forecasts have plunged. Copper is down 13%, and iron and steel prices have tumbled.
More than 20,000 coronavirus cases have been confirmed worldwide—an eight-fold increase over the last week—and experts say hundreds of thousands may not yet have been diagnosed. Two dozen or so countries have reported cases, and many have restricted travel from China to limit the contagion. Companies are evacuating employees from China.
Most businesses in Wuhan where the virus originated have shut down as China has quarantined 56 million or so people in the province of Hubei. Businesses across the mainland are extending the Lunar New Year holiday or directing employees to work from home. Apple, McDonald’s, Levi Strauss and Starbucks have temporarily closed stores.
U.S. manufacturers such as Ford, Apple and Tesla have temporarily halted production. One-sixth of Apple sales and nearly half of chip-maker Qualcomm’s revenues come from China. So do 80% of active ingredients used by drug-makers to produce finished medicines. Because China is the world’s largest manufacturer and an enormous consumer market, the economic freeze will disrupt supply chains and reduce corporate earnings.
I think they’re wrong or, at the very least, exaggerating but let’s dig into that a little bit more. First, these words
80% of active ingredients used by drug-makers to produce finished medicines
are made in China should fill you with dread. Just a few years ago food ingredients from China adulterated with melamine killed who knows how many dogs? To this day we don’t know whether it was an accident, malice, or fraud. There is materially no legal recourse for damage done by Chinese suppliers. We can stop doing business with them. That’s about it. Despite that experience not only most pharmaceutical active ingredients but nearly all food additives, i.e. anything that changes a food product’s taste, look, or nutritional content, is produced in China.
Who should bear the risks of supply chains that run through China? As I pointed out some time ago 98% of the economic surplus realized by that is captured by producers not by consumers. The answer is obvious: producers should bear the risk.
How much will a one week suspension of production cost Ford, Apple, or Tesla? A two week. I submit that it will cost them nothing or, at most, the costs will be temporary. I would also suggest that if those producers don’t have enough inventory to hold them through a brief hiatus they are being reckless.
Finally, I don’t recall the editors of the WSJ ever warning that there were risks associated with doing business with Chinese suppliers. Hoocoodanode? Being dependent on sole sources is a risk, too, and the reality is that all too frequently multiple Chinese suppliers are actually a single supplier with multiple nameplates. How would you ever know?